MarketCapTrends
AQST
Aquestive Therapeutics Inc. (AQST)
NASDAQ

Aquestive Therapeutics Inc. Shareholder Equity 2017–2025

Aquestive Therapeutics Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Aquestive Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were -33.7M, a 44.04% decrease year-over-year.
  • Aquestive Therapeutics Inc. shareholder equity for 2025 were -33.7M, a 44.04% decrease from 2024.
  • Aquestive Therapeutics Inc. shareholder equity for 2024 were -60.2M, a 43.51% decrease from 2023.
  • Aquestive Therapeutics Inc. shareholder equity for 2023 were -106.5M, a 10.18% decrease from 2022.
  • Aquestive Therapeutics Inc. shareholder equity for 2022 were -118.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Aquestive Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$-34
2024$-60
2023$-106
2022$-119
2021$-82
2020$-48
2019$-6
2018$10
2017$-26
Aquestive Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$-34
2024-12-31$-60
2023-12-31$-106
2022-12-31$-119
2021-12-31$-82
2020-12-31$-48
2019-12-31$-6
2018-12-31$10
2017-12-31$-26

Aquestive Therapeutics Inc. Shareholder Equity — FAQ

Aquestive Therapeutics Inc. (AQST) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AQST's shareholder equity history?

The chart and table above show Aquestive Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.